Acrivon Therapeutics, Inc. Common Stock (ACRV)
ACRV Stock Price Chart
Explore Acrivon Therapeutics, Inc. Common Stock interactive price chart. Choose custom timeframes to analyze ACRV price movements and trends.
ACRV Company Profile
Discover essential business fundamentals and corporate details for Acrivon Therapeutics, Inc. Common Stock (ACRV) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Nov 2022
Employees
75.00
Website
https://www.acrivon.comCEO
Peter Blume-Jensen
Description
Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves as a precision medicine tool. It is instrumental in developing drug-specific OncoSignature companion diagnostics, which are designed to pinpoint individuals most likely to benefit from the company's therapeutic candidates. Acrivon's flagship clinical asset is ACR-368, a selective small molecule inhibitor that targets both CHK1 and CHK2. This candidate is currently undergoing a potentially pivotal Phase 2 trial for a range of advanced tumor types, notably including platinum-resistant ovarian, endometrial, and bladder cancers. Beyond its lead program, the company is also cultivating several early-stage pipeline programs. These initiatives concentrate on crucial regulatory points within the DNA damage response and cell cycle regulation pathways, specifically identifying targets such as the protein kinases WEE1 and PKMYT1. Established in 2018, Acrivon Therapeutics, Inc. maintains its headquarters in Watertown, Massachusetts.
ACRV Financial Timeline
Browse a chronological timeline of Acrivon Therapeutics, Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.49, while revenue estimate is $386.33k.
Earnings released on 13 May 2026
EPS came in at -$0.49 matching the estimated -$0.49.
Earnings released on 19 Mar 2026
EPS came in at -$0.49 matching the estimated -$0.49.
Earnings released on 13 Nov 2025
EPS came in at -$0.47 surpassing the estimated -$0.57 by +17.54%.
Earnings released on 13 Aug 2025
EPS came in at -$0.55 surpassing the estimated -$0.57 by +3.51%.
Earnings released on 14 May 2025
EPS came in at -$0.51 surpassing the estimated -$0.57 by +10.53%.
Earnings released on 27 Mar 2025
EPS came in at -$0.60 surpassing the estimated -$0.69 by +13.04%.
Earnings released on 13 Nov 2024
EPS came in at -$0.59 falling short of the estimated -$0.56 by -5.36%.
Earnings released on 13 Aug 2024
EPS came in at -$0.52 surpassing the estimated -$0.59 by +11.86%.
Earnings released on 14 May 2024
EPS came in at -$0.73 surpassing the estimated -$0.89 by +17.98%.
Earnings released on 28 Mar 2024
EPS came in at -$0.86 falling short of the estimated -$0.72 by -19.44%, while revenue for the quarter reached $1.88m .
Earnings released on 9 Nov 2023
EPS came in at -$0.66 surpassing the estimated -$0.72 by +8.33%.
Earnings released on 11 Aug 2023
EPS came in at -$0.63 surpassing the estimated -$0.68 by +7.35%.
Earnings released on 9 May 2023
EPS came in at -$0.58 surpassing the estimated -$0.60 by +3.33%.
Earnings released on 28 Mar 2023
EPS came in at -$0.80 surpassing the estimated -$1.09 by +26.61%.
Earnings released on 14 Nov 2022
EPS came in at -$0.47 surpassing the estimated -$2.44 by +80.78%.
Earnings released on 14 Aug 2022
EPS came in at -$0.44 .
Earnings released on 15 May 2022
EPS came in at -$0.56 .
Earnings released on 14 Feb 2022
EPS came in at -$0.17 .
Earnings released on 31 Dec 2021
EPS came in at -$0.34 .
ACRV Stock Performance
Access detailed ACRV performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
